- Home
- AMST vs VYNE Comparison
AMST vs VYNE Comparison
Compare AMST & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMST | VYNE |
|---|---|---|
| Founded | 2017 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8M | 12.5M |
| IPO Year | 2020 | 2018 |
Fundamental Metrics
Financial Performance| Metric | AMST | VYNE |
|---|---|---|
| Price | $2.32 | $0.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 16.0K | ★ 870.3K |
| Earning Date | 10-24-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $193,505.00 | ★ $524,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 68.56 | 6.29 |
| 52 Week Low | $2.00 | $0.28 |
| 52 Week High | $6.27 | $4.30 |
Technical Indicators
Market Signals| Indicator | AMST | VYNE |
|---|---|---|
| Relative Strength Index (RSI) | 41.60 | 53.79 |
| Support Level | $2.25 | $0.37 |
| Resistance Level | $2.48 | $0.39 |
| Average True Range (ATR) | 0.16 | 0.03 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 81.40 | 62.76 |
Price Performance
Historical ComparisonAbout AMST Amesite Inc.
Amesite Inc is an artificial intelligence-driven platform and course designer that rapidly provides customized, high-performance and scalable online products for schools and businesses. The company helps educational institutions and businesses improve learning as their technology partner, delivering a disruptive technology driven by AI and offers a constellation of services that help partners implement new programs, and improve existing ones. Its customers are Enterprises, universities, and K-12 schools.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.